No pharmacological therapies are currently approved for DR, excepted the drugs to treat diabetic macular edema (DME) such as the anti-vascular endothelial growth factor (VEGF) or steroids administered by intraocular route. The gene discussed is VEGFA; the disease is diabetic macular edema.